Sun Pharmaceutical Industries Ltd.
BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1924.05
-11.20 (-0.58%) Sun Pharmaceutical Industries informs about press release
Date: 28-07-2016Sun Pharmaceutical Industries has informed about a Press Release dated July 27, 2016 titled ‘Almirall and Sun Pharma enter into a License Agreement for Tildrakizumab in Europe for Psoriasis.’
The above information is a part of company’s filings submitted to BSE.